Browse studies

Find your next paid study

27,293 recruiting studies available now

Efficacy Of Auricular Transcutaneous Vagus Nerve Stimulation In Treating Chronic Dizziness

The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatmen…

Chronic DizzinessPersistent Postural Perceptual Dizziness

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07420803

Phase 3

A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir Versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

This randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients …

Adenovirus Infections

Estimated

~$50 – $2,100

Actual pay is set by the research site.

SymBio PharmaceuticalsNCT07387367

Phase 2

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in de Novo Metastatic to Lymph Nodes Prostate Cancer

To learn about the effectiveness of adding talazoparib to the standard of care treatment combination of androgen ablation therapy (hormone therapy, also known …

Prostate Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT05873192

Phase 2

Novel Regenerative Therapeutic in Chronic Complex TBI

This study will determine if allopregnanolone (ALLO) improves depression and pain symptoms in patients who have a history of mild traumatic brain injury (TBI) …

Traumatic Brain Injury (TBI)

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT04003285

Cohort of Repeat Donor Experiences (CORE) Study

The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort st…

FatigueAcute IllnessSelf-rated Health+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

WestatNCT07543965

Phase 1

Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)

The goal of this clinical trial is to learn whether intratumoral (injected directly into the tumor) fluorescently labeled nivolumab (nivo800) is safe for adult…

HNSCCSCC - Squamous Cell CarcinomaOral Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Vanderbilt-Ingram Cancer CenterNCT07741565

Phase 4

A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study

This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive…

Migraine

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Mayo ClinicNCT06972056

Observational

A Pilot Trial of a Community-Based Strategy to Improve Colorectal and Breast Cancer Screening

The goal of the proposed study is to conduct a pilot randomized controlled trial (RCT) of Chi gung, a community-based intervention using peer education and tai…

Colorectal NeoplasmsBreast Neoplasms

Estimated

~$10 – $750

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT07748377

Phase 2

VATCH (Vascular Anomaly Analysis for Therapy Choice): A Phase II Study of Trametinib Treatment in Subjects With Ras/MAPK Pathway Driven Vascular Anomalies

The purpose of this study is to assess the effectiveness and safety of Trametinib (the "Study Drug") in patients with Ras/MAPK pathway driven vascular anomalie…

Ras/MAPK Pathway Vascular AnomaliesVascular AnomaliesVascular Anomaly

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT07549646

Phase 3

A Phase III, Multicentre, Randomised Controlled Study to Evaluate the Efficacy and Safety of AZD2265 (FPI-2265) ²²⁵Ac-PSMA-I&T Compared With Standard of Care in Patients With PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free surv…

Metastatic Castration-resistant Prostate Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT07611110

Phase 2

Strategy for Improving Stroke Treatment Response (SISTER) Trial

SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS…

Ischemic Stroke

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Translational Sciences, Inc.NCT05948566

Phase 1

A Phase 1b/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy Following Fosigotifator Administration in Adult and Pediatric Subjects With Vanishing White Matter Disease

Fosigotifator is an investigational drug being researched for the treatment of Vanishing White Matter disease in adult, pediatric and infant participants. This…

Vanishing White Matter Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Calico Life Sciences LLCNCT05757141